Name | KANONFARMA PRODAKSHN, ZAO |
|---|
INN | 5050026081 |
|---|
KPP | 505001001 |
|---|
OGRN | 1025006523520 |
|---|
OKPO | 48811452 |
|---|
FFSM | 23321-H |
|---|
Address | 141100, MOSKOVSKAYA OBLAST', Schelkovo, ul. Zarechnaya, d. 105 |
|---|
Phone | 797-99-54 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 21.20 | Core activity | Manufacturers of drugs and pharmaceuticals and medical products | | 21.10 | Additional activity | Manufacture of manmade fibres | | 41.20 | Additional activity | Construction of buildings | | All types of activities | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | 52.21.2 | Additional activity | Activities auxiliary relating to road transport | | 52.24 | Additional activity | Cargo handling |
Registration date | 22.11.2002 |
|---|
Registering department | Moskovskaya oblastnaya registratsionnaya palata |
|---|
|
KANONFARMA PRODAKSHN, ZAO (Moscow Oblast; INN 5050026081) was registered on 22 Nov 2002. The company's authorized capital as of July 1, 2012 was 700000 rub. Type of ownership of KANONFARMA PRODAKSHN, ZAO - Closed joint-stock companies. Form of ownership of KANONFARMA PRODAKSHN, ZAO - Private property. Principal activities of KANONFARMA PRODAKSHN, ZAO: manufacturers of drugs and pharmaceuticals and medical products (21.20), manufacture of manmade fibres (21.10), construction of buildings (41.20). |
Economic indicators2021
Net profit (RAS) of KANONFARMA PRODAKSHN, ZAO over 2021 was the same as in 2020 reaching 3.07 billion RUB, the company informed. Revenue increased in the accounting period by 6.35% to 11.99 billion RUB from 11.27 billion RUB over 2020; cost of goods sold grew by 20.86% to 3.88 billion RUB from 3.21 billion RUB; sales profit fell by 0.79% to 6.35 billion RUB from 6.40 billion RUB. 2020
Net profit (RAS) of KANONFARMA PRODAKSHN, ZAO grew over 2020 by 35.52% to 3.18 billion RUB from 2.35 billion RUB over 2019, the company informed. Revenue increased in the accounting period by 34.07% to 11.27 billion RUB from 8.41 billion RUB over 2019; cost of goods sold grew by 34.21% to 3.16 billion RUB from 2.36 billion RUB; sales profit went up by 38.12% to 6.56 billion RUB from 4.75 billion RUB. 2019
Net profit (RAS) of KANONFARMA PRODAKSHN, ZAO grew over 2019 by 42.65% to 2.35 billion RUB from 1.64 billion RUB over 2018, the company informed. Revenue increased in the accounting period by 28.36% to 8.41 billion RUB from 6.55 billion RUB over 2018; cost of goods sold grew by 36.97% to 2.36 billion RUB from 1.72 billion RUB; sales profit went up by 29.03% to 4.75 billion RUB from 3.68 billion RUB. 2018
Net profit (RAS) of KANONFARMA PRODAKSHN, ZAO grew over 2018 by 29.64% to 1.64 billion RUB from 1.27 billion RUB over 2017, the company informed. Revenue increased in the accounting period by 15.35% to 6.55 billion RUB from 5.68 billion RUB over 2017; cost of goods sold grew by 8.08% to 1.72 billion RUB from 1.59 billion RUB; sales profit went up by 21.85% to 3.68 billion RUB from 3.02 billion RUB. 2017
Net profit (RAS) of KANONFARMA PRODAKSHN, ZAO grew over 2017 by 25.04% to 1.27 billion RUB from 1.02 billion RUB over 2016, the company informed. Revenue increased in the accounting period by 39.47% to 5.68 billion RUB from 4.07 billion RUB over 2016; cost of goods sold grew by 24.05% to 1.59 billion RUB from 1.28 billion RUB; sales profit went up 1.54 times to 3.02 billion RUB from 1.96 billion RUB. 2016
Net profit (RAS) of KANONFARMA PRODAKSHN, ZAO grew over 2016 2.12 times to 1.01 billion RUB from 475.71 million RUB over 2015, the company informed. Revenue increased in the accounting period by 48.67% to 4.07 billion RUB from 2.74 billion RUB over 2015; cost of goods sold grew 1.55 times to 1.28 billion RUB from 830.38 million RUB; sales profit went up 1.59 times to 1.96 billion RUB from 1.23 billion RUB. 2014
Net profit (RAS) of KANONFARMA PRODAKSHN, ZAO grew over 2014 1.98 times to 186.44 million RUB from 94.26 million RUB over 2013, the company informed. Revenue increased in the accounting period by 17.92% to 1.70 billion RUB from 1.45 billion RUB over 2013; cost of goods sold grew by 14.66% to 552.26 million RUB from 481.67 million RUB; sales profit went up by 13.51% to 584.62 million RUB from 515.02 million RUB. 2013
Net profit (RAS) of KANONFARMA PRODAKSHN, ZAO dropped in 2013 2.31 times to 94.26 million RUB from 218.18 million RUB over the same period in 2012, the company informed. Revenue decreased in the accounting period by 9.38% to 1.45 billion RUB from 1.60 billion RUB in 2012; cost of goods sold decreased by 2.62% to 481.67 million RUB from 494.65 million RUB; sales profit fell by 16.82% to 515.02 million RUB from 619.17 million RUB. 2012
Net profit (RAS) of Kanonfarma prodakshn, ZAO grew over 2012 by 40.92% to 218.17 billion RUB from 154.82 billion RUB over 2011, the company informed. Cost of goods sold grew by 31.65% to 494.65 billion RUB from 375.72 billion RUB; sales profit went up 1.76 times to 619.17 billion RUB from 351.25 billion RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|